PORTFOLIO NEWS RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update March 30, 2020 Read More » Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology March 30, 2020 Read More » Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis March 25, 2020 Read More » NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights March 17, 2020 Read More » Circle Pharma raises $45 Million in Series B Financing March 17, 2020 Read More » Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline March 12, 2020 Read More » Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights March 11, 2020 Read More » Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2019 Financial Results March 10, 2020 Read More » Revolution Medicines’ New Clinical Trial Exploring Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute March 9, 2020 Read More » Aetna Wun Trombley, Ph.D. to Step Down as President and Chief Operating Officer of NGM Bio to Assume Chief Executive Officer Role at Undisclosed Privately Held Company March 9, 2020 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Next »
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update March 30, 2020 Read More »
Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology March 30, 2020 Read More »
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis March 25, 2020 Read More »
NGM Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights March 17, 2020 Read More »
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline March 12, 2020 Read More »
Gritstone Oncology Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights March 11, 2020 Read More »
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2019 Financial Results March 10, 2020 Read More »
Revolution Medicines’ New Clinical Trial Exploring Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute March 9, 2020 Read More »
Aetna Wun Trombley, Ph.D. to Step Down as President and Chief Operating Officer of NGM Bio to Assume Chief Executive Officer Role at Undisclosed Privately Held Company March 9, 2020 Read More »
